Literature DB >> 9834822

The accuracy of staging: an important prognostic determinator in stage I ovarian carcinoma. A multivariate analysis.

G Zanetta1, S Rota, S Chiari, C Bonazzi, G Bratina, V Torri, C Mangioni.   

Abstract

BACKGROUND: Several prognostic factors for stage I ovarian carcinoma have been analyzed. Some of them are biological and clinical in nature, but others such as the thoroughness of the staging procedure, the extent of the surgery and the philosophy of treatment, are defined by the human element. PATIENTS AND METHODS: We reviewed the records of 351 patients with Stage I ovarian cancer who had been treated from 1981 to 1991. For all patients the following information was available: age, size of the tumor, FIGO sub-stage, tumor grade, histologic type, rupture of the tumor, cytology, extent of the staging and of the surgery (hysterectomy and bilateral salpingo-oophorectomy vs. fertility-conserving surgery) and use of adjuvant treatments. The thoroughness of the staging was defined as: optimal staging: total abdominal hysterectomy and bilateral salpingo-oophorectomy or fertility-conserving surgery, peritoneal cytology or washing, omentectomy, multiple peritoneal biopsies, sampling of the retroperitoneal nodes or formal lymphadenectomy, peritoneal staging: all the criteria described above were met with the exception of retroperitoneal sampling, incomplete staging: lack of any of the previously-cited criteria.
RESULTS: An optimal staging was performed in 100 patients, a peritoneal staging in 107 and an incomplete staging in 144. Radical surgery was performed in 295 women and fertility-conserving surgery in 56. With a median follow-up of 108 months (range 14-184) 64 patients had recurrence of the tumor. Fifty-three died of the disease, two are currently alive with disease and nine were salvaged by surgery and/or chemotherapy. In a multivariate analysis only the tumor grade and the type of staging were significant independent prognostic factors for both disease-free and overall survival.
CONCLUSIONS: As described by other authors, we confirm that tumor grade is the single most important biological prognostic factor in early ovarian carcinoma. The thoroughness of the staging impacts significantly on survival, particularly in poorly differentiated carcinomas. Fertility-sparing surgery is not associated with a worse outcome than standard radical surgery.

Entities:  

Mesh:

Year:  1998        PMID: 9834822     DOI: 10.1023/a:1008424527668

Source DB:  PubMed          Journal:  Ann Oncol        ISSN: 0923-7534            Impact factor:   32.976


  11 in total

1.  The omentum.

Authors:  Cameron Platell; Deborah Cooper; John M Papadimitriou; John C Hall
Journal:  World J Gastroenterol       Date:  2000-04       Impact factor: 5.742

2.  Treatment guidelines in ovarian cancer.

Authors:  A Poveda Velasco; A Casado Herráez; A Cervantes Ruipérez; D Gallardo Rincón; E García García; A González Martín; G López García; C Mendiola Fernández; B Ojeda González
Journal:  Clin Transl Oncol       Date:  2007-05       Impact factor: 3.405

Review 3.  Adjuvant (post-surgery) chemotherapy for early stage epithelial ovarian cancer.

Authors:  Brett A Winter-Roach; Henry C Kitchener; Theresa A Lawrie
Journal:  Cochrane Database Syst Rev       Date:  2012-03-14

Review 4.  Platinum-based adjuvant chemotherapy on moderate- and high-risk stage I and II epithelian ovarian cancer patients. Long-term single institution experience and literature review.

Authors:  José A García-Sáenz; Ana Custodio; Antonio Casado; José Antonio Vidart; Pluvio J Coronado; Miguel Martín; Sara López-Tarruella; Javier Puente; Cristina Fernández; Eduardo Díaz-Rubio
Journal:  Clin Transl Oncol       Date:  2011-02       Impact factor: 3.405

5.  Four cycles of paclitaxel and carboplatin as adjuvant treatment in early-stage ovarian cancer: a six-year experience of the Hellenic Cooperative Oncology Group.

Authors:  Aristotle Bamias; Christos Papadimitriou; Eleni Efstathiou; Alexandros Rodolakis; Georgios Vlahos; Zannis Voulgaris; Georgios Bozas; Georgios Fountzilas; Gerassimos Aravantinos; Evagelia Razis; Dimitra Gika; Meletios A Dimopoulos
Journal:  BMC Cancer       Date:  2006-09-25       Impact factor: 4.430

6.  Pregnancy Outcomes after Conservative Surgery for Early-Stage Ovarian Neoplasms

Authors:  Panwad Ratanasrithong; Mongkol Benjapibal
Journal:  Asian Pac J Cancer Prev       Date:  2017-08-27

7.  Prognostic impact of p16 and p53 gene expressions in stage 1a epithelial ovarian cancer.

Authors:  Emre Günakan; Yusuf Aytaç Tohma; Latife Atasoy Karakaş; Hüseyin Akıllı; Asuman Nihan Haberal; Ali Ayhan
Journal:  Obstet Gynecol Sci       Date:  2020-06-19

Review 8.  Adjuvant (post-surgery) chemotherapy for early stage epithelial ovarian cancer.

Authors:  Theresa A Lawrie; Brett A Winter-Roach; Pauline Heus; Henry C Kitchener
Journal:  Cochrane Database Syst Rev       Date:  2015-12-17

9.  Prognostic factors in early-stage ovarian cancer.

Authors:  Germana Tognon; Mario Carnazza; Monica Ragnoli; Stefano Calza; Federico Ferrari; Angela Gambino; Valentina Zizioli; Sara Notaro; Benedetta Sostegni; Enrico Sartori
Journal:  Ecancermedicalscience       Date:  2013-06-13

10.  Role of primary surgery in advanced ovarian cancer.

Authors:  Karsten Münstedt; Folker E Franke
Journal:  World J Surg Oncol       Date:  2004-10-02       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.